• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床淋巴结阴性甲状腺微小乳头状癌患者中央淋巴结转移危险因素的识别及预防性中央区颈淋巴结清扫对分期迁移和风险分层影响的评估

Identification of risk factors of central lymph node metastasis and evaluation of the effect of prophylactic central neck dissection on migration of staging and risk stratification in patients with clinically node-negative papillary thyroid microcarcinoma.

作者信息

Yuan Jiru, Li Jinghua, Chen Xiaoyi, Lin Xiaodong, Du Jialin, Zhao Gang, Chen Zhengbo, Wu Zeyu

机构信息

Guangdong Academy of Medical Sciences, Guangdong General Hospital, Department of General Surgery, 106, Zhong Shan Second Road, 510080 Guangzhou, Guangdong Province, China.

Guangdong Academy of Medical Sciences, Guangdong General Hospital, Department of Pathological Medicine, 106, Zhong Shan Second Road, 510080 Guangzhou, Guangdong Province, China.

出版信息

Bull Cancer. 2017 Jun;104(6):516-523. doi: 10.1016/j.bulcan.2017.03.005. Epub 2017 May 2.

DOI:10.1016/j.bulcan.2017.03.005
PMID:28476312
Abstract

OBJECTIVE

The first aim of this study was to explore the risk factors that were associated with central lymph node metastasis (CLNM) in patients with clinically node-negative papillary thyroid microcarcinoma (cN PTMC) after prophylactic central neck dissection (PCND). The second aim was to evaluate the influence of PCND on migration of TNM staging and risk stratification (RS) in patients with cN PTMC.

METHODS

A total of 295 cN PTMC patients who underwent thyroidectomy with PCND in the Department of General Surgery at Guangdong General Hospital between March 2014 to December 2015 were assessed retrospectively. The relations of CLNM with clinicopathologic characteristics of cN PTMC were analyzed by univariate and multivariate logistic regression. The effect of PCND on migration of TNM staging and RS was also observed.

RESULTS

The incidence of CLNM was 42.4% (125 of 295 cases) in patients with cN PTMC. Univariate analysis showed that age (P=0.000), ultrasonographic tumor size (P=0.009), pathologic tumor size (P=0.005), and multifocality (P=0.031) were significantly associated with the incidence of CLNM. No significant correlations were found between the presence of CLNM and other variables such as gender (P=0.399), bilaterality (P=0.118), capsular invasion (P=0.111), lymphovascular invasion (P=0.184), extent of thyroidectomy (P=0.319) and lymphadenectomy (P=0.458). Multivariate logistic regression analysis revealed that age <45 years (P=0.000) and multifocality (P=0.033) were independent predictors of CLNM in patients with cN PTMC. Because of the identification of CLNM in the implementation of PCND, 42 (14.2%) patients were upstaged, and 118 (40.0%) patients upgraded in RS.

CONCLUSIONS

CLNM is highly prevalent in cN PTMC. Age <45 years and multifocality are independent risk factors of CLNM in cN PTMC patients. PCND can identify CLNM, which allows more accurate TNM staging/RS and may have an important impact on postoperative treatment in cN PTMC patients.

摘要

目的

本研究的首要目的是探讨在接受预防性中央区颈淋巴结清扫术(PCND)的临床淋巴结阴性的甲状腺微小乳头状癌(cN PTMC)患者中,与中央区淋巴结转移(CLNM)相关的危险因素。第二个目的是评估PCND对cN PTMC患者TNM分期和风险分层(RS)迁移的影响。

方法

回顾性评估2014年3月至2015年12月期间在广东省人民医院普通外科接受甲状腺切除术并进行PCND的295例cN PTMC患者。通过单因素和多因素逻辑回归分析CLNM与cN PTMC临床病理特征之间的关系。同时观察PCND对TNM分期和RS迁移的影响。

结果

cN PTMC患者中CLNM的发生率为42.4%(295例中的125例)。单因素分析显示,年龄(P=0.000)、超声检查肿瘤大小(P=0.009)、病理肿瘤大小(P=0.005)和多灶性(P=0.031)与CLNM的发生率显著相关。未发现CLNM的存在与其他变量之间存在显著相关性,如性别(P=0.399)、双侧性(P=0.118)、包膜侵犯(P=0.111)、脉管侵犯(P=0.184)、甲状腺切除范围(P=0.319)和淋巴结清扫范围(P=0.458)。多因素逻辑回归分析显示,年龄<45岁(P=0.000)和多灶性(P=0.033)是cN PTMC患者CLNM的独立预测因素。由于在实施PCND过程中发现了CLNM,42例(1

相似文献

1
Identification of risk factors of central lymph node metastasis and evaluation of the effect of prophylactic central neck dissection on migration of staging and risk stratification in patients with clinically node-negative papillary thyroid microcarcinoma.临床淋巴结阴性甲状腺微小乳头状癌患者中央淋巴结转移危险因素的识别及预防性中央区颈淋巴结清扫对分期迁移和风险分层影响的评估
Bull Cancer. 2017 Jun;104(6):516-523. doi: 10.1016/j.bulcan.2017.03.005. Epub 2017 May 2.
2
Evaluating the influence of prophylactic central neck dissection on TNM staging and the recurrence risk stratification of cN0 differentiated thyroid carcinoma.评估预防性中央区颈淋巴结清扫术对cN0分化型甲状腺癌TNM分期及复发风险分层的影响。
Bull Cancer. 2016 Jun;103(6):535-40. doi: 10.1016/j.bulcan.2016.04.003. Epub 2016 May 25.
3
Predictors for central lymph node metastases in CN0 papillary thyroid microcarcinoma (mPTC): A retrospective analysis of 1304 cases.CN0 期甲状腺微小乳头状癌中央区淋巴结转移的预测因素:对 1304 例病例的回顾性分析。
Asian J Surg. 2019 Apr;42(4):571-576. doi: 10.1016/j.asjsur.2018.08.013. Epub 2018 Oct 19.
4
Management of cN0 papillary thyroid microcarcinoma patients according to risk-scoring model for central lymph node metastasis and predictors of recurrence.根据中央淋巴结转移风险评分模型和复发预测因素管理 cN0 甲状腺微小乳头状癌患者。
J Endocrinol Invest. 2020 Dec;43(12):1807-1817. doi: 10.1007/s40618-020-01326-1. Epub 2020 Jun 18.
5
The incidence and risk factors for central lymph node metastasis in cN0 papillary thyroid microcarcinoma: a meta-analysis.cN0 期甲状腺微小乳头状癌中央区淋巴结转移的发生率及危险因素:一项荟萃分析
Eur Arch Otorhinolaryngol. 2017 Mar;274(3):1327-1338. doi: 10.1007/s00405-016-4302-0. Epub 2016 Sep 19.
6
Risk Factors for Nodal Metastasis in cN0 Papillary Thyroid Microcarcinoma.cN0 期甲状腺微小乳头状癌发生淋巴结转移的危险因素
Asian Pac J Cancer Prev. 2015;16(8):3361-3. doi: 10.7314/apjcp.2015.16.8.3361.
7
Clinical and pathologic predictors of central lymph node metastasis in papillary thyroid microcarcinoma: a retrospective cohort study.甲状腺微小乳头状癌中央区淋巴结转移的临床病理预测因素:一项回顾性队列研究。
J Endocrinol Invest. 2018 Apr;41(4):403-409. doi: 10.1007/s40618-017-0759-y. Epub 2017 Sep 7.
8
Independent Risk Factors Predicting Central Lymph Node Metastasis in Papillary Thyroid Microcarcinoma.预测甲状腺微小乳头状癌中央淋巴结转移的独立危险因素
Horm Metab Res. 2017 Mar;49(3):201-207. doi: 10.1055/s-0043-101917. Epub 2017 Mar 28.
9
Risk factors for predicting central lymph node metastasis in papillary thyroid microcarcinoma (CN0): a study of 273 resections.预测甲状腺微小乳头状癌(CN0)中央区淋巴结转移的风险因素:273 例切除标本的研究。
Eur Rev Med Pharmacol Sci. 2017 Oct;21(17):3801-3807.
10
Should central lymph node dissection be considered for all papillary thyroid microcarcinoma?所有甲状腺微小乳头状癌都应考虑行中央区淋巴结清扫吗?
Asian J Surg. 2016 Oct;39(4):197-201. doi: 10.1016/j.asjsur.2015.02.006. Epub 2015 Apr 22.

引用本文的文献

1
The necessity of prophylactic central lymph node dissection in clinically n0 papillary thyroid carcinoma: perspective from the endemic region.临床N0期甲状腺乳头状癌预防性中央区淋巴结清扫的必要性:来自流行地区的观点
Langenbecks Arch Surg. 2025 Mar 28;410(1):109. doi: 10.1007/s00423-025-03667-y.
2
Is conservative treatment always safe in unifocal clinically T1a/node-negative papillary thyroid carcinoma?对于单灶临床T1a/淋巴结阴性的乳头状甲状腺癌,保守治疗总是安全的吗?
World J Surg. 2025 Jan;49(1):187-197. doi: 10.1002/wjs.12440. Epub 2024 Dec 4.
3
Central Neck Dissection in Papillary Thyroid Carcinoma: Benefits and Doubts in the Era of Thyroid Lobectomy.
甲状腺乳头状癌的中央区颈淋巴结清扫术:甲状腺叶切除术时代的益处与疑问
Biomedicines. 2024 Sep 25;12(10):2177. doi: 10.3390/biomedicines12102177.
4
Risk factors associated with lymph node metastasis in patients with small papillary thyroid carcinomas.小乳头状甲状腺癌患者淋巴结转移的相关危险因素。
Int J Clin Exp Pathol. 2023 May 20;16(5):86-93. eCollection 2023.
5
Toluidine blue for the detection of sentinel lymph nodes in patients with thyroid cancer.甲苯胺蓝用于检测甲状腺癌患者的前哨淋巴结。
Contemp Oncol (Pozn). 2022;26(4):259-267. doi: 10.5114/wo.2022.124585. Epub 2022 Dec 30.
6
The risk of central nodal metastasis based on prognostic factors of the differentiated thyroid carcinoma: a systematic review and meta-analysis study.基于分化型甲状腺癌预后因素的中央区淋巴结转移风险:一项系统评价和荟萃分析研究。
Eur Arch Otorhinolaryngol. 2023 Jun;280(6):2675-2686. doi: 10.1007/s00405-023-07863-8. Epub 2023 Feb 10.
7
A novel tool for predicting the risk of central lymph node metastasis in patients with papillary thyroid microcarcinoma: a retrospective cohort study.一种用于预测甲状腺微小乳头状癌患者中央区淋巴结转移风险的新工具:一项回顾性队列研究。
BMC Cancer. 2022 Jun 2;22(1):606. doi: 10.1186/s12885-022-09655-5.
8
Clinicopathologic predictors of central lymph node metastases in clinical node-negative papillary thyroid microcarcinoma: a systematic review and meta-analysis.临床隐匿性甲状腺微小乳头状癌中央区淋巴结转移的临床病理预测因素:系统评价和荟萃分析。
World J Surg Oncol. 2022 Apr 1;20(1):106. doi: 10.1186/s12957-022-02573-7.
9
[Correlation between conventional ultrasound features and BRAFV600E gene mutation and central lymph node metastasis in thyroid papillary carcinoma].[甲状腺乳头状癌常规超声特征与BRAFV600E基因突变及中央区淋巴结转移的相关性]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2022 Mar;36(3):184-188. doi: 10.13201/j.issn.2096-7993.2022.03.006.
10
Papillary Thyroid Microcarcinoma: A Nomogram Based on Clinical and Ultrasound Features to Improve the Prediction of Lymph Node Metastases in the Central Compartment.甲状腺微小乳头状癌:基于临床和超声特征的列线图,以提高中央区淋巴结转移的预测准确性。
Front Endocrinol (Lausanne). 2022 Jan 12;12:770824. doi: 10.3389/fendo.2021.770824. eCollection 2021.